Exam 70-122 Topic 1 Question 33 Discussion

You are a licensing specialist. Your customer is Contoso Pharmaceuticals, a growing pharmaceutical company.
Company Background
Contoso Pharmaceuticals has two divisions in the United States, one division in
Switzerland, and two divisions in England. The company is purchasing a small competitor in Germany that has a Select License agreement at Level A for applications and systems.
The agreement includes Software Assurance Membership.
In the past year, Contoso Pharmaceuticals expanded much more rapidly than it had anticipated. The companys growth will likely continue. Additional competitors might be acquired.
Network Description
The Contoso Pharmaceuticals network contains 11,500 desktops. The desktops run
Microsoft Windows XP Professional. Desktops in most locations run Microsoft Office
Professional. Desktops in some locations run third-party applications. The company network contains Microsoft Exchange servers and Microsoft Windows servers.
Current Licensing Solution
Contoso Pharmaceuticals holds a Select 6.x License agreement. When the company entered the Select License agreement, the number of forecasted purchases qualified
Contoso Pharmaceuticals for the Level B discount in applications and systems. As the company approaches its first anniversary, it has accumulated 20,000 points in the
Applications pool and 12,000 points in the Systems pool.
Business Goals
Each division plans and budgets its own software purchases. This purchase model works for Contoso Pharmaceuticals, but the executive team wants to look for ways to optimize the companys information technology (IT) investments and to ensure a more predictable budget.
The executive team is evaluating whether it should manage the IT environment and budget for the entire enterprise and standardize all desktops to use the same applications and operating systems. The team wants to save money and to ensure that collaboration among divisions and locations is more efficient. The team does not know if the benefits of standardization will outweigh the costs of training end users and the IT department to use the new software.
End of repeated scenario
You need to identify the current software acquisition model for Contoso Pharmaceuticals.
Which model should you identify?